Our specialty is cancer. Our mission is saving lives.
We create better, more hopeful futures for people living with cancer. It’s in our DNA.
As a leader in oncology testing, we endeavor to remove the complexities of diagnosing cancer and to empower oncologists, pathologists, and our pharma and biotech partners to provide patients with the best care possible. NeoGenomics enables precision oncology with the most advanced and comprehensive testing menu, ensuring you and your patients are equipped with the tools to optimize care.
All Patients, All Stages, All Clinical Needs
DIAGNOSTIC SERVICES
Precision oncology is the foundation of personalized patient care. And with a comprehensive portfolio of 650+ diagnostic tests covering all key testing methodologies – including broad-panel DNA and RNA-based next-generation sequencing – we have the solutions for your oncology testing requirements.
PHARMA SERVICES
With unparalleled expertise, flexibility, and scalability, we provide you with dedicated support for your oncology-focused research and clinical trials in biomarker discovery, developing a companion diagnostic, and custom assay design and development. We work directly with you - our pharma and biotech partners - to help you navigate through translational research and global clinical trial testing through FDA filing, launch preparation, and commercialization.
INFORMATICS
We understand the vital role that data plays in precision oncology. We harness the power of data to facilitate the discovery and development of new therapeutic options, support clinical trial matching, assess therapy outcomes, and deliver personalized care.
Patients
NeoGenomics partners with you and your cancer care team, leveraging our expertise to uncover the best treatment options for your personalized cancer care.
